[1] CONTRAINDICATIONS History of hypersensitivity reaction to tirzepatide Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) PRECAUTIONS Kidney disease No dose adjustment is recommended in patients with any degree of renal impairment Liver disease No dose adjustment is recommended in patients with any degree of liver disease Stomach disorders Tirzepatide slows gastric emptying and is not recommended in patients with significant stomach disorders, including diabetic gastroparesis General anesthesia or deep sedation GLP-1 therapies, like tirzepatide, slow gastric emptying, possibly increasing the risk of residual gastric contents and pulmonary aspiration in patients receiving anesthesia or deep sedation for procedures
This may surprise you, as it surprised me
Should I stop my GLP-1 if I have body aches
This approach shows promise in animal models but has not yet produced an FDA-approved oral peptide product for systemic delivery
At Klinic, we connect you with skilled healthcare providers who evaluate if a Zepbound prescription is right for you
01 02 (Mark-Vu) 03 1:1 04 05 () , , ,